NPM1, FLT3, KIT, and IDH1/2 are commonly mutated in Ph + AML, while ABL1, RUNX1, ASXL1, and IKZF1 mutations are common in CML-MBC. Here, IDH1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.